Doctor profile · Federal record
Dr. Jeffrey Lertdilok, FNP-C
Family Nurse Practitioner (CMS: Nurse Practitioner) · Carrollton, TX
- NPI 1720621071
- Accepts Medicare
- MIPS 49.4 / 100 · 2023
- 7 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4100 Fairway Dr Ste 320
Carrollton, TX 750106537
(972) 236-7608 - Mailing address
-
4132 Catawba Ave
Carrollton, TX 750101196
Credentials & registration
- NPI registered
- October 2019 — 7 yrs on file
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Texas #AP142915
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720621071. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
147,858
Distinct HCPCS
10
Medicare allowed
$3,294,087
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0485 |
Injection, belatacept, 1 mg | 39,853 | 12 | $3 | |
J0174 |
Injection, lecanemab-irmb, 1 mg | 29,300 | 11 | $1 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 28,500 | 24 | $1 | |
J3245 |
Injection, tildrakizumab, 1 mg | 14,100 | 65 | $138 | |
J0897 |
Injection, denosumab, 1 mg | 13,080 | 170 | $23 | |
J2182 |
Injection, mepolizumab, 1 mg | 9,400 | 11 | $29 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,650 | 13 | $42 | |
J2357 |
Injection, omalizumab, 5 mg | 5,220 | 13 | $38 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 595 | 264 | $62 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 404 | 111 | $53 |
In context: peer comparison
Among 12 peers in Carrollton Family Nurse Practitioner, average services per provider: 2,527. This provider delivers 59× the peer median.Open Payments
Industry payments received
All-time total
$714
Transactions
22
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 4 | $254.87 | |
| Amgen INC. | 7 | $215.49 | |
| Lilly USA, LLC | 2 | $48.38 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $40.58 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $27.67 | |
| Invivyd INC | 1 | $24.43 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $24.10 | |
| Lundbeck LLC | 1 | $22.17 | |
| Tg Therapeutics, INC. | 1 | $20.59 | |
| Hospira, INC. | 1 | $20.14 | |
| Biogen, INC. | 1 | $15.77 |
By nature of payment
Frequently asked questions
What is Dr. Jeffrey Lertdilok's medical specialty?
Dr. Jeffrey Lertdilok practices Family Nurse Practitioner in Carrollton, TX.
Where does Dr. Jeffrey Lertdilok practice?
Dr. Jeffrey Lertdilok practices at 4100 Fairway Dr Ste 320, Carrollton, TX 750106537. Office phone: 9722367608.
What is Dr. Jeffrey Lertdilok's NPI?
Dr. Jeffrey Lertdilok's National Provider Identifier (NPI) is 1720621071, issued by NPPES.
Does Dr. Jeffrey Lertdilok accept Medicare assignment?
Yes. Dr. Jeffrey Lertdilok accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Lertdilok commonly perform?
Top Medicare-reported procedures in 2023: Injection, belatacept, 1 mg (HCPCS J0485); Injection, lecanemab-irmb, 1 mg (HCPCS J0174); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439). Source: CMS Medicare Physician & Other Practitioners file.